Copyright
©The Author(s) 2024.
World J Clin Cases. Feb 16, 2024; 12(5): 942-950
Published online Feb 16, 2024. doi: 10.12998/wjcc.v12.i5.942
Published online Feb 16, 2024. doi: 10.12998/wjcc.v12.i5.942
Index | Before treatment | After treatment | t value | P value |
Daily life activity rating | 3.8 ± 0.9 | 5.4 ± 1.3 | 5.67 | < 0.05 |
Social activity rating | 3.7 ± 1.0 | 4.8 ± 0.7 | 5.92 | < 0.05 |
Emotional state score | 4.6 ± 1.1 | 5.3 ± 1.2 | 3.15 | < 0.05 |
Symptom score | 4.4 ± 1.2 | 5.2 ± 0.9 | 3.37 | < 0.05 |
SAQLI scale score | 4.2 ± 0.5 | 4.8 ± 0.4 | 8.94 | < 0.05 |
ESS scale score | 14.8 ± 5.7 | 10.2 ± 4.3 | 3.31 | < 0.05 |
- Citation: Qian B, Chen ZJ, Wang YS, Hu XY, Hu XB, Zheng YH. Clinical efficacy and mechanism study of mid-frequency anti-snoring device in treating moderate obstructive sleep apnea-hypopnea syndrome. World J Clin Cases 2024; 12(5): 942-950
- URL: https://www.wjgnet.com/2307-8960/full/v12/i5/942.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i5.942